Venture Capital Analyst Intern - Spring 2025 (Remote)

Posted
December 6, 2023
Job description
Company Overview
Chromie Health is an AI-driven healthcare startup revolutionizing work force management to help healthcare organizations optimize staffing, reduce inefficiencies, and improve patient care through cutting-edge technology.
We are seeking venture capital analyst interns to join our team and gain hands-on experience in investment research, fundraising strategy, and the intersection of AI and healthcare innovation. This role is ideal for individuals passionate about venture capital, startup funding, and emerging technologies.
About the Role
As a venture capital analyst intern, you will work closely with our leadership team to identify investment opportunities, develop fundraising strategies, and support investor relations. You will gain exposure to the startup funding process, venture capital landscape, and financial modeling while contributing to the growth of an early-stage AI healthcare company.
Key Responsibilities
- Conduct venture capital market research to identify potential investors, funding trends, and competitive landscapes in AI and healthcare technology.
- Build and maintain a database of venture capital firms, angel investors, and grant opportunities.
- Develop investor outreach strategies, assisting in preparing pitch decks and funding presentations.
- Analyze startup funding rounds and investment patterns in the digital health and AI sectors.
- Assist in financial modeling and valuation analysis to support strategic decision-making.
- Research global healthcare regulations and business incorporation strategies for potential expansion.
- Explore emerging technologies investment opportunities in healthcare and contribute to the 5-10 year strategic roadmap.
What We Offer
- Real-world impact – contribute to meaningful projects in healthcare policy, AI ethics, and regulatory analysis, influencing the future of digital health and workforce management.
- Flexible remote work – enjoy remote work flexibility (10-15 hours per week) while working on impactful projects.
- Direct mentorship – gain one-on-one mentorship from Chromie Health’s leadership team, providing insights into healthcare innovation, startup growth, and AI policy.
- Startup experience – work in a fast-paced, high-growth startup environment, gaining hands-on exposure to business strategy, venture capital, and cutting-edge technology.
- Networking opportunities – connect with healthcare executives, AI leaders, venture capitalists, and policymakers through meetings, industry events, and mentorship.
- Opportunities for research publications – contribute to industry reports, white papers, and policy briefs that could be published or presented to stakeholders.
- Professional development resources – access resume reviews, LinkedIn profile optimization, career coaching, and personal branding workshops to advance your career.
- Letters of recommendation – high-performing interns will receive personalized letters of recommendation for future job or graduate school applications.
- Access to industry events and webinars – gain exclusive invitations to healthcare, AI, and venture capital conferences, webinars, and networking events.
- Potential for future opportunities – top interns may be considered for full-time positions, future internships, or referrals within Chromie Health’s network.
Who Should Apply
We are looking for highly motivated candidates with a strong interest in venture capital, startup investing, and AI-driven healthcare innovation. Ideal applicants should have:
- Strong analytical and research skills in venture capital, finance, or business strategy.
- Background in finance, economics, business, data science, or a related field.
- Interest in AI, digital health, and emerging technologies.
- Excellent financial modeling and presentation skills.
- Ability to work independently and collaborate in a fast-paced startup environment.
How to Apply
Submit your resume to careers@chromiehealth.com with the subject line "Venture Capital Analyst Intern – Spring 2025."